Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Chemical Engineering · India · 2022-10-04

Processing Time
156 days
Decision Date
2022-10-04
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses chronic health conditions responsible for 90% of U.S. healthcare expenditures and has received funding from the NSF and DoD.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of experience, 20 publications, and a patent, demonstrating a track record of success in chemical engineering.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's ability to advance drug delivery for critical diseases makes his presence beneficial to the U.S. without a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 20 peer-reviewed journal articles, 162 citations, and 24 peer reviews for authoritative journals. Evidence included a patent, 8 years of research experience, and funding from prestigious organizations like the NSF and U.S. Department of Defense, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 180 days 2025-08-20
The petitioner proposes to continue research on biomolecular delivery vehicles to create novel drug delivery systems. This work focuses on enhancing drug targeting, controlled release, and bioavailability for the treatment of cancer and chronic diseases.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
New York 169 days 2025-04-09
The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Chemicals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 156 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist